SARS-CoV-2 spike (S), nucleocapsid (N), and membrane (M) protein epitopes (SARS-CoV-2 S/N/M epitopes)

SARS-CoV-2 spike, nucleocapsid, and membrane protein epitopes are the key molecular fragments of the SARS-CoV-2 virus recognized by the human immune system. The Spike (S) protein is a large transmembrane glycoprotein that mediates viral attachment and membrane fusion via the ACE2 receptor, making it the primary target for neutralizing antibodies and most first-generation vaccines (UniProt P0DTC2). The Nucleocapsid (N) protein is an internal protein that binds to the viral RNA genome, playing a vital role in viral replication and assembly, and is highly immunogenic for T-cell responses (UniProt P0DTC9). The Membrane (M) protein is the most abundant structural protein, essential for organizing the viral assembly process and maintaining the envelope structure (UniProt P0DTC5). Together, these epitopes are utilized in the development of diagnostic assays, multi-antigen vaccines, and adoptive T-cell therapies to provide comprehensive immunity against COVID-19. Therapeutic strategies targeting these proteins aim to block viral entry, inhibit replication, or clear infected cells through cytotoxic T-lymphocyte activity.

Other names

SARS-CoV-2 structural protein epitopesSARS-CoV-2 S, N, and M antigensSevere acute respiratory syndrome coronavirus 2 structural proteinsS/N/M protein fragments

Neutralization of viral entry by blocking the receptor-binding domain (RBD) of the Spike protein, and induction of T-cell mediated cytotoxicity against cells presenting Spike, Nucleocapsid, or Membrane epitopes.